diphenylhydantoin/obesity

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

6 rezilta yo

Effect of diphenylhydantoin on patterns of insulin secretion in obese subjects.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The effect of short-term treatment with diphenylhydantoin (DPH) on the insulin secretion patterns during OGTT and on the daily insulin profile was studied in obese patients. DPH treatment for 3 days with a dose of 300 mg/die (100 mg, 3 times daily) significantly decreased the insulin release after

[Insulin secretion in obese patients treated with diphenylhydantoin (DPH)].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Effects of age, sex, obesity, and pregnancy on plasma diphenylhydantoin levels.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Effects of nafenopin, diphenylhydantoin, phenobarbitone and some acetylenes on body composition: is there a relationship between decreased carcass lipid and increased liver size and induction of drug metabolizing enzymes?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Administration of nafenopin, diphenylhydantoin, phenobarbitone or the acetylenes BRL 15268 and BRL 19001 in the diet or, in the case of phenobarbitone, in drinking water reduced the body-lipid content of genetically-obese (ob/ob) mice. These compounds also reduced food intake in ob/ob mice. However,

Human jejunal brush border folate conjugase. Characteristics and inhibition by salicylazosulfapyridine.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Human jejunal brush border folate conjugase (EC 3.4.22.-) was partially purified and characterized. Three drugs known to be associated with clinical folate deficiency were tested for inhibition of the partially purified enzyme. Using jejunal mucosa from obese patients undergoing intestinal bypass

Single-dose metyrapone test: review of a four-year experience.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Subnormal plasma 11-deoxycortisol (compound S) responses to metyrapone were found in patients with adrenal insufficiency or with Cushing syndrome caused by adrenal tumors and in those receiving long-term glucocorticoid or diphenylhydantoin sodium therapy. High normal or exaggerated responses were

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye